BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36990390)

  • 1. Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG).
    Kubo N; Suefuji H; Nakajima M; Tokumaru S; Okano N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
    Radiother Oncol; 2023 Jun; 183():109640. PubMed ID: 36990390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
    Okano N; Suefuji H; Nakajima M; Tokumaru S; Kubo N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
    J Radiat Res; 2023 Jun; 64(Supplement_1):i2-i7. PubMed ID: 37036751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG).
    Kubo N; Suefuji H; Nakajima M; Tokumaru S; Okano N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shimizu K; Shioyama Y
    J Thorac Oncol; 2024 Mar; 19(3):491-499. PubMed ID: 37924974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon-ion radiotherapy for patients with advanced stage non-small-cell lung cancer at multicenters.
    Karube M; Yamamoto N; Shioyama Y; Saito J; Matsunobu A; Okimoto T; Ohno T; Tsuji H; Nakano T; Kamada T
    J Radiat Res; 2017 Sep; 58(5):761-764. PubMed ID: 28992088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.
    Nakajima M; Yamamoto N; Hayashi K; Karube M; Ebner DK; Takahashi W; Anzai M; Tsushima K; Tada Y; Tatsumi K; Miyamoto T; Tsuji H; Fujisawa T; Kamada T
    Radiat Oncol; 2017 Sep; 12(1):144. PubMed ID: 28865463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).
    Takahashi W; Nakajima M; Yamamoto N; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Kamada T; Fujisawa T
    Cancer; 2015 Apr; 121(8):1321-7. PubMed ID: 25641119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy.
    Karube M; Yamamoto N; Tsuji H; Kanematsu N; Nakajima M; Yamashita H; Nakagawa K; Kamada T
    Radiother Oncol; 2017 Oct; 125(1):31-35. PubMed ID: 28784437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Carbon-ion Radiotherapy Alone for Stage III Non-small Cell Lung Cancer.
    Anzai M; Yamamoto N; Hayashi K; Nakajima M; Nomoto A; Ogawa K; Tsuji H
    Anticancer Res; 2020 Jan; 40(1):379-386. PubMed ID: 31892590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer.
    Jeong J; Taasti VT; Jackson A; Deasy JO
    Radiother Oncol; 2020 Dec; 153():265-271. PubMed ID: 32976878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study.
    Shirai K; Kawashima M; Saitoh JI; Abe T; Fukata K; Shigeta Y; Irie D; Shiba S; Okano N; Ohno T; Nakano T
    PLoS One; 2017; 12(4):e0175589. PubMed ID: 28399182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon-ion radiotherapy for octogenarians with locally advanced non-small-cell lung cancer.
    Hayashi K; Yamamoto N; Nakajima M; Nomoto A; Ishikawa H; Ogawa K; Tsuji H
    Jpn J Radiol; 2021 Jul; 39(7):703-709. PubMed ID: 33608792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Dose Escalation Clinical Trial of Single-Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.
    Yamamoto N; Miyamoto T; Nakajima M; Karube M; Hayashi K; Tsuji H; Tsujii H; Kamada T; Fujisawa T
    J Thorac Oncol; 2017 Apr; 12(4):673-680. PubMed ID: 28007628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Fraction Carbon-Ion Radiation Therapy for Patients 80 Years of Age and Older With Stage I Non-Small Cell Lung Cancer.
    Karube M; Yamamoto N; Nakajima M; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Fujisawa T; Kamada T
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):542-548. PubMed ID: 26797538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of carbon-ion radiotherapy versus stereotactic body radiotherapy for non-small-cell lung cancer.
    Okazaki S; Shibuya K; Takura T; Miyasaka Y; Kawamura H; Ohno T
    Cancer Sci; 2022 Feb; 113(2):674-683. PubMed ID: 34820994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of carbon-ion radiotherapy for locally advanced non-small-cell lung cancer.
    Hayashi K; Yamamoto N; Nakajima M; Nomoto A; Tsuji H; Ogawa K; Kamada T
    Cancer Sci; 2019 Feb; 110(2):734-741. PubMed ID: 30467928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
    Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
    Ball D; Mai GT; Vinod S; Babington S; Ruben J; Kron T; Chesson B; Herschtal A; Vanevski M; Rezo A; Elder C; Skala M; Wirth A; Wheeler G; Lim A; Shaw M; Schofield P; Irving L; Solomon B;
    Lancet Oncol; 2019 Apr; 20(4):494-503. PubMed ID: 30770291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and radiation pneumonitis after concurrent EGFR-tyrosine kinase inhibitors and radiotherapy for unresectable stage III non-small cell lung cancer.
    Xu K; Liang J; Zhang T; Zhou Z; Chen D; Feng Q; Xiao Z; Hui Z; Lu J; Wang X; Deng L; Liu W; Wang J; Zhai Y; Wang J; Bi N; Wang L
    Thorac Cancer; 2021 Mar; 12(6):814-823. PubMed ID: 33501781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I Study of Hypofractionated Carbon-ion Radiotherapy for Stage III Non-small Cell Lung Cancer.
    Saitoh JI; Shirai K; Abe T; Kubo N; Ebara T; Ohno T; Minato K; Saito R; Yamada M; Nakano T;
    Anticancer Res; 2018 Feb; 38(2):885-891. PubMed ID: 29374716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.